Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Asterias Biotherapeutics, Inc. | 380,000 | reported | 09 Nov 2015 | tx 1+380,000 |
| CODEXIS, INC. | 316,100 | reported | 23 Feb 2026 | tx 7+854,225−10,065 |
| Zosano Pharma Corp | 115,750 | reported | 25 May 2017 | tx 5+463,250 |
| Harpoon Therapeutics, Inc. | 115,000 | reported | 28 Jan 2022 | tx 13+452,367−72,292 |
| Coherus Oncology, Inc. | 112,000 | reported | 12 Jun 2025 | tx 3+280,000 |
| ARTELO BIOSCIENCES, INC. | 22,250 | reported | 29 Aug 2019 | tx 1+22,250 |
| AXONYX INC | 16,100 | reported | 13 May 2014 | tx 6+289,900−7,400 |
| ProNAi Therapeutics Inc | 0 | reported | 01 Jul 2022 | tx 2+18,000−18,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | GRANT_AWARD | CODEXIS, INC. | 316,100 | 0.00 USD | deriv |
| 06 Feb 2026 | SALE | CODEXIS, INC. | 3,826 | 1.31 USD | |
| 13 Oct 2025 | SALE | CODEXIS, INC. | 6,239 | 2.51 USD | |
| 12 Jun 2025 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 05 Feb 2025 | GRANT_AWARD | CODEXIS, INC. | 26,875 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | CODEXIS, INC. | 161,250 | 0.00 USD | deriv |
| 10 Oct 2024 | GRANT_AWARD | CODEXIS, INC. | 50,000 | 0.00 USD | |
| 10 Oct 2024 | GRANT_AWARD | CODEXIS, INC. | 300,000 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Coherus Oncology, Inc. | 114,000 | 0.00 USD | deriv |
| 20 Feb 2024 | GRANT_AWARD | Coherus Oncology, Inc. | 54,000 | 0.00 USD | deriv |
| 01 Jul 2022 | OTHER | ProNAi Therapeutics Inc | 18,000 | 0.00 USD | deriv |
| 28 Jan 2022 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 115,000 | 0.00 USD | deriv |
| 11 Nov 2021 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 115,000 | 0.00 USD | deriv |
| 22 Sept 2021 | PURCHASE | Harpoon Therapeutics, Inc. | 10,300 | 8.10 USD | first after silence |
| 02 Jun 2021 | GRANT_AWARD | ProNAi Therapeutics Inc | 18,000 | 0.00 USD | deriv |
| 17 Feb 2021 | EXERCISE | Harpoon Therapeutics, Inc. | 25,000 | 2.12 USD | |
| 17 Feb 2021 | EXERCISE | Harpoon Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 72,000 | 0.00 USD | deriv |
| 19 Aug 2020 | PURCHASE | Harpoon Therapeutics, Inc. | 5,000 | 11.40 USD | |
| 18 Aug 2020 | PURCHASE | Harpoon Therapeutics, Inc. | 2,098 | 11.60 USD | |
| 31 Jul 2020 | PURCHASE | Harpoon Therapeutics, Inc. | 1,817 | 10.92 USD | |
| 31 Jan 2020 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 52,160 | 0.00 USD | deriv |
| 21 Jan 2020 | PURCHASE | Harpoon Therapeutics, Inc. | 6,700 | 14.09 USD | first after silence |
| 04 Dec 2019 | EXERCISE | Harpoon Therapeutics, Inc. | 47,292 | 2.12 USD | |
| 04 Dec 2019 | EXERCISE | Harpoon Therapeutics, Inc. | 47,292 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 22 Sept 2021.